Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Saturday, August 2 2014 12:45am ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Drug Manufacturers - Major
Composite Value: 993.2
Today's Change: +0.02%
S&P 500: -0.29%
chart for
[Drug Manufacturers - Major (^YHOh783)]
Drug Manufacturers - Major News
FDA approves Jardiance® (empagliflozin) tablets for adults with type 2 diabetes
1 hour, 19 minutes ago (PR Newswire)
RIDGEFIELD, Conn., and INDIANAPOLIS, Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (LLY) today announced the U.S. Food and Drug Administration (FDA) approved Jardiance® (empagliflozin) tablets as an adjunct to diet and exercise to improve glycemic control, or blood glucose levels, in adults with type 2 diabetes (T2D). JARDIANCE is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine). JARDIANCE works by blocking the reabsorption of glucose in the kidney, increasing glucose excretion and lowering blood glucose levels in adults with T2D who have elevated blood glucose levels. Patients should not take JARDIANCE if they have severe kidney problems or are on dialysis, or if they are allergic to empagliflozin or any ingredient in JARDIANCE.
Zogenix Announces Departure of Chief Commercial Officer, Scott Shively - (GlobeNewswire)
FDA approves Lilly, Boehringer diabetes drug - (AP)
More News on Drug Manufacturers - Major: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
REAL NUTRI [2010.HK] +6.81% $0
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
GLAXOSMITHKLINE [GSK.L] -1.39% $6809.7 B
ASTRAZENECA [AZN.L] -0.14% $5411.5 B
JOHNSON & JOHNSON [JNJ.MX] -0.64% $3770.6 B
ROCHE HLDG SP ADR [RHHBYN.MX] +1.15% $2979.9 B
PFIZER [PFE.MX] +0.26% $2513.2 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
08/04/14 HRTX Q2 2014 Heron Therapeutics Inc Earnings Release- Tentative
08/05/14 ZGNX Zogenix Inc Earnings Call (Q2 2014)
08/06/14 GWP.L GW Pharmaceuticals PLC Q3 2014 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/01/14 LLY Eli Lilly and Company Common St coverage initiated by Tigress Financial
07/31/14 AZN Astrazeneca PLC Common Stock upside earnings surprise (+19.27%)
07/31/14 AZN.L ASTRAZENECA upside earnings surprise (+18.18%)
More Recent Events...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
www.OmegaStatistics.com
Accelerated Study Start
Clinical trial site identification, feasibility, and activation.
www.ePharmaSolutions.com
Health Care Consulting
Go To Local.com To Find Local Businesses And Services Near You!
Local.com
(What's This?)
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:24,270B
Price / Earnings:21.6
Price / Book:28.5
Net Profit Margin (mrq):20.8%
Price To Free Cash Flow (mrq):-369.3
Return on Equity:21.1%
Total Debt / Equity:108.6
Dividend Yield:3.3%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
GSK
SGP
BDSI
Unusually Active Boards
Board Variance
BDSI
SGP
JNJ

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?